UNIVERSITY OF CALIFORNIA, DAVIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1905-01-01

Employees: 10K

Market Cap: -

Website: http://www.ucdavis.edu

Clinical Trials

Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen

Phase 3

Withdrawn

Conditions: Hayfever

Interventions: Biological: Lactobacillus acidophilus L-92

First Posted Date: 2007-11-07

Last Posted Date: 2015-04-22

Lead Sponsor: University of California, Davis

Registration Number: NCT00554736

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Phase 2

Terminated

Conditions: Diabetes Complications
Fatty Liver

Interventions: Drug: exenatide

First Posted Date: 2007-09-14

Last Posted Date: 2017-06-20

Lead Sponsor: University of California, Davis

Target Recruit Count: 1

Registration Number: NCT00529204

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Procedure: Infant feeding counseling that includes Flash-heat

First Posted Date: 2007-08-31

Last Posted Date: 2012-02-14

Lead Sponsor: University of California, Davis

Target Recruit Count: 144

Registration Number: NCT00523510

Locations: 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Early Phase 1

Completed

Conditions: Age-related Macular Degeneration

Interventions: Drug: Proton beam irradiation and ranibizumab

First Posted Date: 2007-08-16

Last Posted Date: 2016-07-11

Lead Sponsor: University of California, Davis

Target Recruit Count: 6

Registration Number: NCT00517010

Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells

Not Applicable

Terminated

Conditions: Melanoma

Interventions: Other: EGIR Tape

First Posted Date: 2007-06-04

Last Posted Date: 2015-04-22

Lead Sponsor: University of California, Davis

Target Recruit Count: 7

Registration Number: NCT00482105

Locations: 🇺🇸
UC Davis Department of Dermatology, Sacramento, California, United States

Abraxane and Alimta in Advanced Solid Tumors

Phase 1

Terminated

Conditions: Breast Cancer
Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Abraxane
Drug: Alimta

First Posted Date: 2007-05-07

Last Posted Date: 2018-01-10

Lead Sponsor: University of California, Davis

Target Recruit Count: 49

Registration Number: NCT00470548

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

Effects of Initiation and Discontinuation of Short Term Zinc Supplementation on Plasma Zinc Concentration

Phase 4

Completed

Conditions: Zinc Deficiency

Interventions: Dietary Supplement: zinc sulfate
Dietary Supplement: Placebo

First Posted Date: 2007-04-12

Last Posted Date: 2010-02-19

Lead Sponsor: University of California, Davis

Target Recruit Count: 58

Registration Number: NCT00459485

Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age

Not Applicable

Completed

Conditions: Vitamin A Deficiency

Interventions: Other: White-fleshed sweet potatoes
Other: WFSP and capsule of retinyl palmitate
Other: Orange-fleshed sweet potatoes (boiled)
Other: Orange-fleshed sweet potatoes (fried)

First Posted Date: 2007-03-29

Last Posted Date: 2017-05-30

Lead Sponsor: University of California, Davis

Target Recruit Count: 130

Registration Number: NCT00453648

Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation

Phase 2

Completed

Conditions: Type 1 Diabetes

First Posted Date: 2007-03-01

Last Posted Date: 2007-03-01

Lead Sponsor: University of California, Davis

Target Recruit Count: 50

Registration Number: NCT00441844

Locations: 🇺🇸
UCDavis Medical Center, Sacramento, California, United States

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: cetuximab
Drug: erlotinib

First Posted Date: 2006-12-07

Last Posted Date: 2017-05-08

Lead Sponsor: University of California, Davis

Target Recruit Count: 64

Registration Number: NCT00408499

Locations: 🇺🇸
University of California Davis Cancer Center, Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy